Nibec Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Mar 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 24, 2026
- Nov 3 US 12,780,940 Protein Comprising Antibody for Targeting Oncogenic Protein or Single Chain Fragment Variable Thereof and Cancer Cell Penetrating Peptide, and Use of the Same
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,349,804 | Bone Graft and Scaffolding Materials Immobilized with Type I Collagen Binding Peptides In force · High confidence | In force | High confidence | |
| US 10,821,065 | Peptide for Inhibiting Biofilms In force · High confidence | In force | High confidence | |
| US 12,486,303 | Novel Use of Peptide for Inhibiting Functions and Expressions of Multiple Disease Biomarkers In force · Medium confidence | In force | Medium confidence | |
| US 11,384,120 | Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereof In force · USPTO record | In force | USPTO record | |
| US 12,161,518 | Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with same In force · USPTO record | In force | USPTO record | |
| US 12,655,413 | Fragmented GRS Polypeptide and Variant Thereof, and Use Thereof In force · High confidence | In force | High confidence | |
| US 12,545,704 | Peptide for Treating Inflammation and Wounds In force · High confidence | In force | High confidence | |
| US 12,698,313 | Bone Morphogenetic PROTEIN-9 and -10 Variants with Enhanced Therapeutic Effect Due to Reduced Side Effects of Ectopic Ossification and Pharmaceutical Composition Comprising Same In force · High confidence | In force | High confidence | |
| US 12,780,940 | Protein Comprising Antibody for Targeting Oncogenic Protein or Single Chain Fragment Variable Thereof and Cancer Cell Penetrating Peptide, and Use of the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 1 patent in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 pending · 2 abandoned
Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/836,830 | Bioabsorbable and Photocurable Composition, Bioabsorbable Guided Tissue Regeneration Composition, and Grafting Method Using Same | Feb 14, 2023 | Pending |
| 18/836,118 | Peptide Having Antibacterial, Anti-Inflammatory or Tissue Regeneration Ability and Use Thereof | Feb 14, 2023 | Pending |
| 18/697,475 | Peptide for Penetrating Blood-Brain Barrier and Use Thereof | Sep 30, 2022 | Pending |
| 18/568,180 | Bio Protac Protein Having Intracellular Delivery Function, and Pharmaceutical Composition Comprising Same | Jun 10, 2022 | Pending |
| 18/567,167 | Nanoparticle Comprising Peptide-Lipid Conjugate for Delivering Oligonucleotide into Target Cell and Pharmaceutical Composition Comprising Same | Jun 10, 2022 | Pending |
| 18/262,543 | Peptide for Preventing and Treating Fibrosis | Jan 24, 2022 | Pending |
| 17/272,010 | Novel Use of Peptide for Inhibiting Functions and Expressions of Multiple Disease Biomarkers | Aug 29, 2019 | Abandoned |
| 16/755,370 | Method for Selecting Highly Efficient Stem Cell, Using Protein Marker GRP78 | Oct 15, 2018 | Pending |
| 16/625,692 | Peptide for Inhibiting Bone Resorption | Jun 19, 2018 | Abandoned |
| 16/623,167 | Integral Biomaterial for Regeneration of Bone Tissue and Fabrication Method Therefor | Jul 27, 2017 | Pending |